Genotic


Genotic is a pioneering company at the intersection of AI and antibody design, dedicated to transforming life science research through computational innovation. Their mission is to accelerate biologics discovery, design custom antibodies, and develop therapeutic solutions ethically and efficiently, leveraging advanced AI algorithms, high-performance computing, and integrated laboratory processes. They focus on rapid, reliable, and high-quality antibody development, aiming to shorten development timelines and enable personalized medicine.

Industries

artificial-intelligence
biotechnology
clinical-trials

Nr. of Employees

small (1-50)


Products

AI-designed monoclonal antibodies (research-grade)

Monoclonal antibodies designed computationally for specific protein targets and validated for common applications (immunofluorescence, immunohistochemistry, flow cytometry, ELISA); typically supplied lyophilized with documentation packages.

Recombinant proteins

Recombinant human, bacterial and other proteins produced in E. coli or mammalian expression systems, supplied lyophilized and characterized for research use.

Enzymes (research-grade)

Isolated and recombinant enzymes characterized for activity and purity, offered with analytical purity metrics and suitable for diagnostic and research applications.

Assay kits (enzyme activity)

Colorimetric and spectrometric activity assay kits for enzymes (e.g., LDH, GAPDH, urease) designed for laboratory use in quantifying enzymatic activity.


Services

Design, produce and validate monoclonal antibodies based on a submitted target 3D structure (.pdb), using computational design, in-house expression and multi-step QC to deliver validated research reagents.

Expertise Areas

  • Antibody engineering and design
  • Computational protein design and optimization
  • High-throughput recombinant expression and purification
  • Analytical characterization of proteins and antibodies
  • Show More (3)

Key Technologies

  • Deep learning for protein and antibody design
  • Graph-based neural networks for structural reasoning
  • Large-scale protein structure prediction models
  • High-performance GPU clusters with low-latency interconnect
  • Show More (5)

News & Updates

Genotic has developed an integrated platform that combines computational design, high-throughput production, and functional validation to reliably deliver functional antibody candidates at scale, bridging the gap between in silico predictions and real-world biological activity.

Genotic shares its journey of using AI to revolutionize antibody design, emphasizing rapid, ethical, and precise development of antibodies for research and therapeutic applications.

An overview of how AI is transforming antibody engineering, reducing development time from months to weeks, and enabling personalized medicine.

Genotic emphasizes its commitment to animal-free, computational antibody design, reducing reliance on traditional animal immunization methods.

High Production Success Rate

99% of AI-designed candidates are successfully produced and purified, validating the predictive power of their in silico assessments.

Scale of Design and Validation

Designed antibodies for approximately 3,000 targets, with over 100 fully validated through various immunoassays.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.